| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-Q | Report | Data | 10-Q | Aug 6, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 6, 2024 | Aug 6, 2024 |
| 8-K | Report | Data | 8-K | Jun 14, 2024 | Jun 13, 2024 |
| 10-Q | Report | Data | 10-Q | May 7, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 7, 2024 | May 7, 2024 |
| 8-K | Report | Data | 8-K | Apr 15, 2024 | Apr 15, 2024 |
| 10-K | Report | Data | 10-K | Mar 7, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | 8-K | Mar 7, 2024 | Mar 7, 2024 |
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G | Report | Feb 13, 2024 | ||
| 8-K | Report | Data | 8-K | Jan 8, 2024 | Jan 8, 2024 |
| SC 13D/A | Report | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1) | Dec 15, 2023 | |
| 8-K | Report | Data | 8-K | Nov 28, 2023 | Nov 27, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 1, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | 8-K | Nov 1, 2023 | Nov 1, 2023 |
| SC 13D | Report | ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D | Oct 2, 2023 | |
| SC 13D | Report | SC 13D | Sep 27, 2023 | |
| 8-K | Report | Data | 8-K | Sep 19, 2023 | Sep 19, 2023 |